SELECT COUNTRY

VIEW ALL

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

ALGERIA ANGOLA ARGENTINA AUSTRALIA AZERBAIJAN BAHREIN BELGIUM BENIN BOLIVIA BOTSWANA BRAZIL BRUNEI BURKINA FASO CAMEROON CANADA CENTRAL AFRICAN REPUBLIC CHAD CHILE CHINA COLOMBIA COTE D’IVOIRE CUBA CZECH REPUBLIC DOMINICAN REPUBLIC DRC ECUADOR EGYPT EQUATORIAL GUINEA ETHIOPIA FINLAND FRANCE GABON GHANA GREENLAND GUATEMALA GUINEA GUYANA HUNGARY ICELAND INDIA INDONESIA IRAN IRAQ ITALY JAMAICA JAPAN KAZAKHSTAN KENYA KUWAIT LESOTHO LIBERIA LIBYA MADAGASCAR MALAWI MALAYSIA MALI MAURITANIE MEXICO MONGOLIA MOROCCO MOZAMBIQUE NAMIBIA NETHERLANDS NICARAGUA NIGER NIGERIA NORWAY PANAMA PAPUA NEW GUINEA PARAGUAY PERU PHILIPPINES POLAND QATAR REPUBLIC OF CONGO RUSSIA RWANDA SAUDI ARABIA SENEGAL SIERRA LEONE SINGAPORE SLOVENIA SOMALI SOUTH AFRICA SOUTH KOREA SPAIN SUDAN SWEDEN TAIWAN TANZANIA THAILAND TOGO TRINDAD & TOBAGO TURKEY TURKMENISTAN UAE UGANDA UKRAINE UNITED KINGDOM UNITED STATES VENEZUELA VIETNAM ZAMBIA ZIMBABWE

PARAGUAY: LATEST INTERVIEWS MORE INTERVIEWS

Claudio Gorichon

CEO, GRUPO RENO

"Grupo Reno has a very well-established position in Chile and Peru, and we want to further strengthen our position in Paraguay and then start building a footprint in Colombia."

Peru

Petrochemicals & Chemicals

Chile

Argentina

Colombia

Paraguay

PARAGUAY: LATEST ARTICLES

No Content Found

PARAGUAY: RECENTLY RELEASED PUBLICATIONS

No Content Found

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

MORE PREVIOUSLY PUBLISHED